{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:54:58Z","timestamp":1788432898133,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bull Exp Biol Med"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s10517-022-05624-x","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T08:03:03Z","timestamp":1667376183000},"page":"730-733","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Selank, a Peptide Analog of Tuftsin, Attenuates Aversive Signs of Morphine Withdrawal in Rats"],"prefix":"10.1007","volume":"173","author":[{"given":"M. A.","family":"Konstantinopolsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I. V.","family":"Chernyakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. G.","family":"Kolik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"1","key":"5624_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0006-8993(95)00279-y","volume":"683","author":"I Nylander","year":"1995","unstructured":"Nylander I, Vlaskovska M, Terenius L. Brain dynorphin and enkephalin systems in Fischer and Lewis rats: effects of morphine tolerance and withdrawal. Brain Res. 1995;683(1):25-35. https:\/\/doi.org\/10.1016\/0006-8993(95)00279-y","journal-title":"Brain Res."},{"issue":"3","key":"5624_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1023\/B:RUBI.0000030126.09208.c3","volume":"30","author":"YA Zolotarev","year":"2004","unstructured":"Zolotarev YuA, Myasoedov NF, Sokolov OYu, Kost NV, Zozulya AA, Vaskovsky BV. Leu-enkephalin generally labeled with tritium in studying the Selank inhibiting effect on the enkephalin-degrading enzymes of human blood plasma. Rus. J. Bioorganic Chemistry. 2004;30(3):207-212. https:\/\/doi.org\/10.1023\/B:RUBI.0000030126.09208.c3","journal-title":"Rus. J. Bioorganic Chemistry."},{"issue":"3","key":"5624_CR3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1254\/jjp.82.175","volume":"82","author":"Y Fukunaga","year":"2000","unstructured":"Fukunaga Y, Kishioka S. Enkephalinergic neurons in the periaqueductal gray and morphine withdrawal. Jpn J. Pharmacol. 2000;82(3):175-180. https:\/\/doi.org\/10.1254\/jjp.82.175","journal-title":"Jpn J. Pharmacol."},{"issue":"2","key":"5624_CR4","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1124\/mol.120.119388","volume":"98","author":"LD Fricker","year":"2020","unstructured":"Fricker LD, Margolis EB, Gomes I, Devi LA. Five decades of research on opioid peptides: current knowledge and unanswered questions. Mol. Pharmacol. 2020;98(2):96-108. https:\/\/doi.org\/10.1124\/mol.120.119388","journal-title":"Mol. Pharmacol."},{"issue":"1-2","key":"5624_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0006-8993(94)91631-4","volume":"645","author":"P Sribanditmongkol","year":"1994","unstructured":"Sribanditmongkol P, Sheu MJ, Tejwani GA. Inhibition of morphine tolerance and dependence by diazepam and its relation to the CNS Met-enkephalin levels. Brain Res. 1994;645(1-2):1-12. https:\/\/doi.org\/10.1016\/0006-8993(94)91631-4","journal-title":"Brain Res."},{"key":"5624_CR6","doi-asserted-by":"publisher","unstructured":"Solov\u2019ev BV, Gengin MT, Latynova IV, Zhigaeva LV, Sollertinskaya TN. Effect of selank on the main carboxypeptidases in the rat nervous tissue. J. Evolution. Biochem. Physiol. 2012;48(3):306-309. https:\/\/doi.org\/10.1134\/S0022093012030073","DOI":"10.1134\/S0022093012030073"},{"issue":"4","key":"5624_CR7","first-page":"38","volume":"108","author":"AA Zozulya","year":"2008","unstructured":"Zozulya AA, Neznamov GG, Syunyakov TS, Kast NV, Gabaeva MV, Sokolov OY, Serebryakova EV, Siranchieva OA, Andryushchenko AV, Telesheva ES, Syunyakov SA, Smulevich \u0410\u0412, Myasoedov NF, Seredenin SB. Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurasthenia. Zh. Nevrol. Psikhiatr. 2008;108(4):38-48. Russian.","journal-title":"Zh. Nevrol. Psikhiatr."},{"issue":"6","key":"5624_CR8","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s10517-019-04430-2","volume":"166","author":"LG Kolik","year":"2019","unstructured":"Kolik LG, Konstantinopolsky MA. Comparative assessment of the effectiveness of noncompetitive NMDA receptor antagonists amantadine and hemantane in morphine withdrawal syndrome model. Bull. Exp. Biol. Med. 2019;166(6):739-743. https:\/\/doi.org\/10.1007\/s10517-019-04430-2","journal-title":"Bull. Exp. Biol. Med."},{"issue":"17","key":"5624_CR9","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1016\/0024-3205(85)90485-0","volume":"37","author":"J Aronowski","year":"1985","unstructured":"Aronowski J, Wleklik M, Gumulka SW, Luczak M, Konopinska D. Modification of morphine withdrawal: effect of tuftsin, [Lys4]-tuftsinyltuftsin, tetrapeptide fragment (1-4) of substance P and its amide. Life Sci. 1985;37(17):1649-1653. https:\/\/doi.org\/10.1016\/0024-3205(85)90485-0","journal-title":"Life Sci."},{"issue":"1","key":"5624_CR10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10517-014-2490-4","volume":"157","author":"LG Kolik","year":"2014","unstructured":"Kolik LG, Nadorova AV, Kozlovskaya MM. Efficacy of peptide anxiolytic selank during modeling of withdrawal syndrome in rats with stable alcoholic motivation. Bull. Exp. Biol. Med. 2014;157(1):52-55. https:\/\/doi.org\/10.1007\/s10517-014-2490-4","journal-title":"Bull. Exp. Biol. Med."},{"issue":"3","key":"5624_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.neuint.2004.10.001","volume":"46","author":"G Larrinaga","year":"2005","unstructured":"Larrinaga G, Gil J, Meana JJ, Ruiz F, Callado LF, Irazusta J. Aminopeptidase activity in the postmortem brain of human heroin addicts. Neurochem. Int. 2005;46(3):213-219. https:\/\/doi.org\/10.1016\/j.neuint.2004.10.001","journal-title":"Neurochem. Int."},{"issue":"2","key":"5624_CR12","first-page":"10","volume":"75","author":"II Kozlovskii","year":"2012","unstructured":"Kozlovskii II, Andreeva LA, Kozlovskaya MM, Nadorova AV, Kolik LG. The role of opioid system in peculiarities of anti-anxiety effect of peptide anxiolytic Selank. Eksper. Klin. Farmakol. 2012;75(2):10-13. Russian.","journal-title":"Eksper. Klin. Farmakol."},{"issue":"2","key":"5624_CR13","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1023\/A:1015582302311","volume":"133","author":"OY Sokolov","year":"2002","unstructured":"Sokolov OYu, Meshavkin VK, Kost NV, Zozulya AA. Effects of Selank on behavioral reactions and activities of plasma enkephalin-degrading enzymes in mice with different phenotypes of emotional and stress reactions. Bull. Exp. Biol. Med. 2002;133(2):133-135. https:\/\/doi.org\/10.1023\/A:1015582302311","journal-title":"Bull. Exp. Biol. Med."},{"issue":"3","key":"5624_CR14","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s11481-006-9019-1","volume":"1","author":"TK Eisenstein","year":"2006","unstructured":"Eisenstein TK, Rahim RT, Feng P, Thingalaya NK, Meissler JJ. Effects of opioid tolerance and withdrawal on the immune system. J. Neuroimmune Pharmacol. 2006;1(3):237-249. https:\/\/doi.org\/10.1007\/s11481-006-9019-1","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"34","key":"5624_CR15","doi-asserted-by":"publisher","first-page":"3711","DOI":"10.2174\/0929867324666170725140826","volume":"24","author":"A Siebert","year":"2017","unstructured":"Siebert A, Gensicka-Kowalewska M, Cholewinski G, Dzierzbicka K. Tuftsin \u2013 properties and analogs. Curr. Med. Chem. 2017;24(34):3711-3727. https:\/\/doi.org\/10.2174\/0929867324666170725140826","journal-title":"Curr. Med. Chem."}],"container-title":["Bulletin of Experimental Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-022-05624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10517-022-05624-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10517-022-05624-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T02:11:48Z","timestamp":1667959908000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10517-022-05624-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["5624"],"URL":"https:\/\/doi.org\/10.1007\/s10517-022-05624-x","relation":{},"ISSN":["0007-4888","1573-8221"],"issn-type":[{"value":"0007-4888","type":"print"},{"value":"1573-8221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"4 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}